Categories: News

Monarq Asset Management Appoints Sam Gaer as CIO to Lead Directional Strategy

NEW YORK, July 21, 2025 /PRNewswire/ — Monarq Asset Management (“Monarq”), a leading multi-strategy investment firm formerly known as MNNC Group, is pleased to announce the appointment of Sam Gaer as Chief Investment Officer to lead its Directional Investment Strategy. With over 25 years of leadership experience across institutional trading, market infrastructure, and systematic asset management, Sam Gaer brings deep expertise to support Monarq’s next phase of growth.

- Advertisement -

Following a decade of success in delta-neutral and market-making strategies, Monarq is expanding its directional capabilities to capture a broader range of risk-adjusted returns. The strategy emphasizes high-conviction themes, asymmetric exposures, and tactical volatility overlays—positioning the firm to navigate evolving market conditions with precision.

- Advertisement -

Monarq’s Directional Strategy has delivered strong performance year-to-date, adhering to disciplined risk and capital allocation. Backed by global institutional capital across its USD and BTC-denominated funds, Monarq is now scaling access to Directional as a complementary source of absolute returns within its platform.

- Advertisement -

“We’re excited to welcome Sam to the team,” said Shiliang Tang, CEO and Managing Partner. “His leadership enhances our ability to compound asymmetric returns and anticipate key catalysts in the digital asset space.”

- Advertisement -

Mr. Gaer previously co-managed BlockTower Capital’s flagship fund and founded Katana Financial, a leading systematic trading firm. He also served as CIO at FINRA and EVP/CIO at NYMEX, where he led major technological transformations and strategic initiatives. He holds a degree in Corporate Finance from the Wharton School of the University of Pennsylvania.

- Advertisement -

About Monarq Asset Management
Monarq Asset Management, formerly MNNC Group, is a multi-strategy digital asset investment manager focused on generating consistent, risk-adjusted returns through all market conditions. Managed by former executives from firms such as LedgerPrime, Tower Research, and BlockTower Capital, the team offers extensive experience in quantitative trading, volatility strategies, and digital market structure.

- Advertisement -

Media Contact: info@monarq-am.com

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/monarq-asset-management-appoints-sam-gaer-as-cio-to-lead-directional-strategy-302509212.html

- Advertisement -

Recent Posts

FemiCore (Official Website & Authenticity Notice 2026) Counterfeit Risks and What Consumers Should Know

New York City, NY, June 13, 2026 (GLOBE NEWSWIRE) -- The women's health supplement market…

5 hours ago

Hitch Open Ping-Pong Embodied (HOPE) AI Challenge Joins the 2026 World Humanoid Robot Games, Seeding Advanced Physical AI Against Human Performance

BEIJING, June 13, 2026 (GLOBE NEWSWIRE) -- The 2026 Hitch Open Ping-Pong Embodied AI Challenge…

5 hours ago

Crypto News Today: AlphaPepe Unveils AlphaSwap Early Access as Bitcoin Price Prediction Eyes $250,000

MONACO, June 12, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe after…

5 hours ago

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies [NSE: HEXT], a…

7 hours ago

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI…

8 hours ago

Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

June 13, 2026 07:30 ET  | Source: Intellia Therapeutics, Inc. Data from HAELO Phase 3…

8 hours ago